Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOLA in Hepatic Encephalopathy
NCT01847651Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Aug 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of l-ornithine l-aspartate in hepatic encephalopathy (HE), sponsored by Imperial College London. Started Aug 2013; status: completed.
02
Drugs
l-ornithine l-aspartate
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT01847651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01847651.